To directly examine whether physiologic hyperinsulinemia regulates insulin receptors in normal man, we studied the effect of insulin infusion (employing the euglycemic insulin clamp technique) on 125 l-insulin binding to monocytes. In Study I (9 subjects), when the steady-state plasma insulin concentration was raised to approximately 100 /tU/ml, insulin binding to monocytes remained unchanged at 1 h, but decreased significantly by 3 h (20%, P < 0.01) and fell further by 5 h (37%, P < 0.001) following the insulin infusion. In Study II (5 subjects) increments in plasma insulin concentration to 31 /nil/ml resulted in no change in insulin binding at 3 h (P > 0.5) but resulted in a significant decrease at 5 h (25%, P < 0.01). The plasma glucose concentration was maintained at basal levels in both infusion protocols. The decrease in insulin binding in both studies was due to a decrease in insulin receptor concentration. No significant change in receptor affinity was observed. In a control study (5 subjects) 5 h of saline infusion had no effect on insulin binding to monocytes.
l-insulin binding to monocytes. In Study I (9 subjects), when the steady-state plasma insulin concentration was raised to approximately 100 /tU/ml, insulin binding to monocytes remained unchanged at 1 h, but decreased significantly by 3 h (20%, P < 0.01) and fell further by 5 h (37%, P < 0.001) following the insulin infusion. In Study II (5 subjects) increments in plasma insulin concentration to 31 /nil/ml resulted in no change in insulin binding at 3 h (P > 0.5) but resulted in a significant decrease at 5 h (25%, P < 0.01). The plasma glucose concentration was maintained at basal levels in both infusion protocols. The decrease in insulin binding in both studies was due to a decrease in insulin receptor concentration. No significant change in receptor affinity was observed. In a control study (5 subjects) 5 h of saline infusion had no effect on insulin binding to monocytes.
We conclude that in normal humans, increments in the plasma insulin concentration in the physiologic range downregulates the number of insulin receptors in a dose-and time-dependent manner. DIABETES 29:159-163, February 1980. R ecent studies have shown that receptors for various polypeptide hormones are regulated by the ambient hormone concentration.
1 " 6 While growth hormone, 2 glucagon, 3 ' 4 and TRH 5 have been shown to downregulate their receptors, prolactin 6 is known to induce its own receptor. These observations have important implications in the modulation of hormone action at the cellular level. With respect to the insulin receptor, Gavin et al. 1 were the first to demonstrate that in vitro exposure (5-16 h) of IM-9 lymphocytes in culture to supraphysiologic, but not physiologic, concentrations of insulin resulted in a decrease in the number of insulin receptors. In vivo studies in animals indicate that chronic (14 days) hyperinsulinemia in healthy rats leads to a decrease in insulin binding to adipocytes. 7 Whether physiologic hyperinsulinemia in humans can regulate insulin receptors has not been examined previously. Indirect evidence for such a possibility has been provided by studies from several laboratories, demonstrating an inverse correlation between insulin binding to monocytes and fasting plasma insulin levels under various conditions. 8 " 13 However, this inverse relationship between insulin binding and insulin concentration does not establish causality and has not been a universal observation.
14 - 15 Consequently the present study, employing the insulin clamp technique, 11 was undertaken to directly examine in humans the effect of physiologic hyperinsulinemia on insulin binding to monocytes. This technique, by maintaining the glucose concentration constant at the basal level, allows one to assess the effect of insulin on its receptor independent of changes in plasma glucose concentration, and avoids the release of counterregulatory hormones which might of themselves affect insulin binding. 16 Our findings indicate that in healthy humans, short-term physiologic hyperinsulinemia leads to a decrease in insulin binding to monocytes.
MATERIALS AND METHODS
Subjects and experimental protocol. Nineteen healthy adults (14 males, 5 females, age 30 ± 3 yr) were studied. All subjects were within 10% of their ideal body weight (Metropolitan Life Insurance Tables, 1959) and were consuming a weight-maintaining diet containing at least 200 g of carbohydrate per day for 3 days before the initiation of the study. None of the subjects were consuming any medication. The purpose, nature, and the potential risks of the study were explained to all subjects before obtaining their voluntary consent to participate in the study.
All studies were performed in the postabsorptive state at 8 a.m. after a 12-h overnight fast. Blood samples were obtained for the determination of fasting plasma glucose and insulin levels and for insulin binding to monocytes before the initiation of glucose and insulin infusions (euglycemic insulin clamp technique). The details of the insulin clamp technique have been described previously.
11
- 17 In Study I (9 subjects) insulin was infused at a rate of 1 mU/kg • min and blood samples were obtained for insulin binding studies at 1 h (N = 4), 3 h (N = 8), and 5, h (N = 5) following insulin infusion. The second study (II) consisted of a separate group of 5 subjects who received an insulin infusion at a rate of 0.25 mU/kg • min. Insulin binding to monocytes was determined at 3 h and 5 h in all 5 subjects. In an additional group of five subjects, insulin binding to monocytes was determined before and after a 5-h saline infusion alone. Analyses. Plasma glucose was measured by the glucose oxidase method and plasma insulin levels were determined by radioimmunoassay.
18 125 l-insulin binding to monocytes was determined by the previously described techniques.
11 ' 14 In the binding assay, mononuclear cells (3-5 x 10 7 cells/ml) were incubated in tubes containing 0.2 ng/ml of 125 l-monoiodoinsulin with and without unlabeled porcine insulin in Hepes buffer, pH 8.0 at 22°C for 3 h. The percentage of monocytes remained unaltered by glucose and insulin infusion (Study I: 16.5 ± 1.5% basal, 16.4 ± 2.0% at 3 h, and 18.0 ± 1.9% at 5 h; Study II: 16.5± 1.2% basal, 17.6 ± 1.2% at 3 h, and 15.9 ± 2.0% at 5 h). Calculations. During insulin clamp studies, the glucose infusion rate and the steady-state plasma glucose and insulin concentrations were determined by calculating the mean of the values observed between various time intervals as shown in Table 1 . Insulin binding data were analyzed by the Scatchard analysis 19 and by the average affinity profile plot method of DeMeyts and Roth. 20 Statistical analyses were done by the paired Student's t test. 21 All data are presented asmean ± SEM.
RESULTS
Study I. During the 1-mU/kg • min insulin clamp study (Table 1) 
FIGURE 1. Effect of insulin infusion (by euglycemic insulin clamp technique) on 125
l-insulin binding to monocytes in 9 healthy subjects. * P < 0 . 0 1 , * * P < 0.001! maintained at 102 ± 6 ^ill/ml. This represented a mean increase of 89 /LtU/ml above basal levels. The plasma glucose concentration was maintained close to the basal level with little variation throughout the study period. The glucose infusion rate required to maintain euglycemia during the insulin clamp study rose rapidly during the first hour of study and then tended to plateau. During the last 3 h of study the increase in glucose metabolism was small, averaging 5% per hour.
The total specific binding of 125 l-insulin to monocytes (determined at the tracer concentration of insulin) remained unaltered at 1 h after the initiation of insulin infusion ( Figure 1 arid Table 2 ). However at 3h, insulin binding fell an average of 20% (P < 0.01), and at 5 h it declined further to levels which were 37% (P < 0.001) below those observed during the basal preinfusion period ( Figure 1 and Table 2 ). The competition curves of insulin binding to monocytes are shown in Figure 2 (upper panel) . At 5 h after the insulin infusion, insulin binding was significantly lower at all insulin concentrations up to 100 ng/ml as compared with the preinfusion study (Figure 2, upper panel) . Scatchard analysis of these data revealed that the Scatchard plots were curvilinear and parallel (Figure 2, lower panel) . The calculated insulin receptor concentration was about 33% lower at 5 h following insulin infusion (9200 ± 750 sites/monocyte) as compared with the basal period (13,500 ± 1050 sites/monocytes, P < 0.005). The average affinity profile plots revealed that both the highest (Ke 0.39 ± 0.04 nM~1 basal and 0.38 ± 0.05 nM~1 after infusion, P > 0.5) and the lowest (K/ 0.06 ± 0.01 nM~1 before and 0.05 ± 0.01 nM~1 after infusion, P > 0.5) insulin binding affinity was not significantly altered during the 5 h infusion period. Similarly, at 3 h during insulin clamp, insulin binding affinity was unchanged (not shown), whereas the insulin receptor concentration decreased by 22% (10,480 ± 490 sites/monocyte, P < 0.01). Study II. When insulin was infused at the rate of 0.25 mil/kg • min, the mean steady-state plasma insulin concentration was 31 ± 2 /xiJ/ml (Table 1) . This represented an in- crease of only 15 /xU/ml above basal levels. Again, the steady-state plasma glucose concentration was maintained at the basal fasting level throughout the study period.
As shown in Figure 1 and Table 2 , the total specific binding of 125 l-insulin to monocytes was unaltered at 3 h after the initiation of insulin infusion, but it fell significantly by 25% (P < 0.01) following 5 h of sustained hyperinsulinemia. The decrease in insulin binding observed at 5 h of insulin infusion was demonstrable at all insulin concentrations examined ( Figure 3, upper panel) . Scatchard analysis (Figure 3 , lower panel) of the insulin binding data showed that at 5 h, the number of binding sites/monocyte (9100 ± 680) were 28% lower as compared with the preinfusion, basal period (12,850 ± 760, P < 0.01). However, the insulin binding affinity, as revealed by the average affinity profile plots, remained unaltered following insulin infusion (Ke 0.35 ± 0.05 nM-1 before and 0.36 ± 0.04 nM~1 at 5'h after infusion, P > 0.5).
In five control subjects receiving saline infusion (5 h), 125 l-insulin binding to monocytes was similar before (7.5 ± 0.5%) and after saline infusion (7.7'± 0.6%, P = NS).
Among the fourteen subjects receiving insulin clamp, we observed an inverse correlation between fasting plasma in- sulin levels and insulin receptor concentration (r = -0.62, P < 0.01).
DISCUSSION
The current data provide direct evidence for in vivo downregulation of insulin receptors by physiologic hyperinsulinemia in normal man. The decrease in insulin binding to monocytes was found to be dependent upon the degree and duration of hyperinsulinemia. When the plasma insulin concentration was increased by 89 /j\J/rr\\ above basal (Study I), a significant decrease in insulin binding was observed at 3 h, which averaged 20 ± 2% (P < 0.01). At 5 h insulin binding declined further (37 ± 3%, Figure 1 ). During Study II, when the plasma insulin concentration was raised by as little as 15 jiiU/ml above basal, the decrease in insulin binding did not become significant until 5 h (Figure 1) , and the magnitude (25 ± 2%) was significantly lower (P < 0.05) than observed with the higher insulin infusion dose (Study I). The analyses of insulin binding data revealed that the decrease in insulin binding in both insulin clamp studies was due entirely to a decrease in insulin receptor concentration without any change in the receptor affinity (Figures 2 and 3) . These data are thus consistent with previous studies demonstrating that homologous regulation of polypeptide hormones generally involves alterations in hormone receptor concentration rather than changes in receptor affinity.
1 "
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The steady-state plasma insulin levels achieved in the present study are well within the physiologic range. In Study I plasma insulin concentration increased to a mean of 102 /nil/ml, a level which is commonly observed following the ingestion of oral glucose. It has been proposed that the decrease in insulin receptor concentration in these insulin resistant states 8 " 11 may be secondary to the elevated fasting insulin levels characteristic of these conditions. This hypothesis has been based on the finding that decreased insulin binding in these patients is inversely correlated with the fasting plasma insulin concentration. 8 -13 However, this observation does not necessarily indicate causality. The current data thus provide direct support for the thesis that the fasting hyperinsulinemia in these insulin-resistant states may, at least in part, be responsible for the decrease in insulin receptor concentration. Although the monocyte is not a conventional target organ for insulin action, previous data have shown that monocytes mirror the changes in insulin receptors in target tissues in both man 22 and animals. 23 Therefore, to the extent that insulin binding to monocytes reflects muscle, adipose, and liver cells, it would appear that physiologic hyperinsulinemia can downregulate insulin receptor concentration in insulin-sensitive target organs.
We considered the possibility that the decrease in insulin binding may have been secondary to insulin bound to monocyte membranes as a direct result of the insulin infusion. This seems unlikely for the following reasons. 1) During the insulin binding assay, multiple washing steps are performed and insulin is known to almost completely dissociate from its membrane receptor under these conditions. 23 2) We failed to observe any decrease in insulin binding at 1 h following insulin infusion, the time required to achieve steadystate binding equilibrium at 37°C. 3) If insulin had bound to the membrane, one would expect an alteration in the shape of the competition curve of insulin binding. This would be most evident at low insulin concentrations, reflecting a change in insulin receptor affinity. No change in affinity was observed in the present study. Since no change in insulin binding was seen in control studies, when saline was infused, it is unlikely that the decrease in binding was the result of diurnal variation.
An obvious question raised by our findings is the possible functional consequence of the downregulation of insulin receptors induced by hyperinsulinemia. In this regard, it is noteworthy that the insulin sensitivity, as reflected by the insulin-mediated glucose uptake (Table I) , did not decrease at 5 h of insulin infusion in Study I. In fact, there was a small (10%) but significant (P < 0.05) increase in insulin-mediated glucose uptake between the third and fifth hours of insulin infusion. It should be pointed out, however, that insulin-mediated glucose uptake, as measured by the insulin clamp technique, reflects an effect of insulin on overall cellular glucose metabolism-a function of post-receptor as well as receptor-mediated events. Thus, it is possible that the decrease in insulin binding was compensated for by an increased efficiency of post-receptor events. Whether more prolonged hyperinsulinemia will result in a decrease in insulin sensitivity remains to be established. In any event, the present findings indicate that in normal human subjects, in-crements in plasma insulin concentration well within the physiologic range are capable of downregulating the number of insulin receptors.
